Avenaciolide Induces Apoptosis in Human Malignant Meningioma Cells through the Production of Reactive Oxygen Species

Biol Pharm Bull. 2022;45(4):517-521. doi: 10.1248/bpb.b21-01039.

Abstract

Malignant meningioma has a poor prognosis and there are currently no effective therapies. Avenaciolide is water-insoluble natural organic product produced by Aspergillus avenaceus G. Smith that can inhibit mitochondrial function. In the present study, we investigated the anti-cancer effects of avenaciolide in an isolated human malignant meningioma cell line, HKBMM. In addition, to assess the specificity of avenaciolide, its effects on normal human neonatal dermal fibroblast HDFn cells were also examined. Avenaciolide showed effective anti-cancer activity, and its cytotoxicity in HKBMM cells was greater than that in HDFn cells. The anti-cancer effects of avenaciolide were mediated by reactive oxygen species (ROS)-induced apoptosis, which may have been caused by mitochondrial disfunction. These results suggest that avenaciolide has potential as a therapeutic drug for malignant meningioma.

Keywords: apoptosis; avenaciolide; malignant meningioma; reactive oxygen species (ROS).

MeSH terms

  • Apoptosis
  • Humans
  • Infant, Newborn
  • Lactones
  • Meningeal Neoplasms*
  • Meningioma* / drug therapy
  • Reactive Oxygen Species / metabolism

Substances

  • Lactones
  • Reactive Oxygen Species
  • avenaciolide